News Conference News ISC 2026 Loberamisal Scores a Rare Win for Stroke Neuroprotection Todd Neale February 12, 2026
News Conference News ISC 2026 OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding Todd Neale February 09, 2026
News Conference News ISC 2026 CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy Todd Neale February 06, 2026
News Conference News ISC 2025 Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy Todd Neale February 11, 2025
News Conference News ISC 2025 Stroke Thrombectomy Doesn’t Help for Blockages in Smaller Vessels Todd Neale February 06, 2025
News Conference News ISC 2024 AI-Based System Boosts Quality of Stroke Care and Reduces Events Todd Neale February 16, 2024
News Conference News ISC 2024 MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone Todd Neale February 08, 2024
News Conference News ISC 2021 Adjustable Stent Retriever Performs Well in IDE Trial Todd Neale March 24, 2021
News Conference News ISC 2019 Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients Todd Neale February 07, 2019
News Conference News ISC 2018 More Stroke Thrombectomy Studies Offer Insights Into Subgroups, New Devices, and Lytic Choice Todd Neale January 31, 2018
News Conference News ISC 2018 Experts Debate: Is It ‘Nuts’ to Restart Anticoagulation After Lobar ICH? Todd Neale January 30, 2018
News Conference News ISC 2018 More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs Todd Neale January 27, 2018
News Conference News ISC 2018 Highly Anticipated COMPASS Results Boost Aspiration for Acute Ischemic Stroke Todd Neale January 26, 2018
News Conference News ISC 2017 Restarting Oral Anticoagulation After Intracerebral Hemorrhage Tied to Better Outcomes Todd Neale February 27, 2017